Nivea says her chronic myeloid leukemia is in remission

Nivea says her chronic myeloid leukemia is in remission, an encouraging turn only months after she publicly disclosed the diagnosis. The R&B singer became emotional as Tamron Hall shared the update during the October 7 episode of ‘The Tamron Hall Show.’ Seated beside her oncologist, Dr. Colin Vale, Nivea said she was ‘very grateful’ and acknowledged that she had not known whether her treatment would work so quickly for her.

The moment was hopeful without pretending the difficult parts had disappeared. Nivea said she continues to deal with fatigue and other health issues while adjusting to treatment. She also spoke about bleeding and fibroids, and made clear that she considers herself fortunate despite the long list. Her treatment is ongoing; reports from the interview say she is participating in a clinical trial involving targeted medications rather than treating remission as the end of medical care.

Nivea, whose full name is Nivea B. Hamilton, first revealed her leukemia diagnosis in July during an appearance on ‘Cadillac Chronicles.’ In a subsequent statement, she identified it as chronic myeloid leukemia, or CML, and said two bone-marrow biopsy procedures were needed before the diagnosis was confirmed. At the time, she said treatment was going well and that the experience had sharpened her gratitude for music, motherhood and everyday life.

CML begins in blood-forming cells in the bone marrow. The American Cancer Society explains that doctors measure response in several ways, including blood counts and tests that look for the disease’s genetic marker. That context matters because remission in CML is not automatically the same as a cure. Many people continue targeted therapy and regular monitoring for years, while treatment changes depend on the depth and durability of each person’s response.

That medical distinction should not diminish what Nivea announced. Reaching remission means treatment has produced a meaningful response, and she chose to share that milestone while still describing the physical cost. Her account gives fans reason to celebrate her progress without turning a private health journey into a promise about what comes next. The most accurate reading is the one she offered herself: gratitude, continued treatment and day-by-day adjustment.

The singer’s public life has long carried more than one chapter. Her early-2000s records include ‘Don’t Mess With My Man,’ ‘Laundromat’ and ‘Okay,’ and her voice also helped make Mystikal’s ‘Danger (Been So Long)’ instantly recognizable. In recent interviews she has described studying audio engineering and preparing new music after years in which family life often took priority. The Tamron Hall episode also looked ahead to what she wants to create, not only back at what she has endured.

That balance is especially important in health coverage of Black women, whose pain and symptoms are too often minimized or turned into inspirational shorthand. Nivea did not owe the public disclosure, and remission does not erase treatment burdens. Reporting the update with care means leaving room for her relief, her fatigue and her control over how much more she chooses to share.

For now, the verified news is both simple and substantial: Nivea and her doctor publicly described her CML as being in remission, and she remains under treatment. No new album date, complete treatment protocol or long-term prognosis was announced in the material reviewed for this article. Her progress deserves celebration on its own terms, without filling those unanswered spaces with speculation.